Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers

Drug Delivery

Volumn 16, Issue 3, 2009, Pages 145-152

  Al Kassas, Raida S ^a   El Khatib, Mona M ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Ciprofloxacin; Controlled release gels; In situ gels; Ophthalmic delivery systems; PH triggered systems

Indexed keywords

CARBOMER; CATION; CIPROFLOXACIN; HYDROXYPROPYLMETHYLCELLULOSE; METHYLCELLULOSE; POLYMER; ALGINIC ACID; ANTIINFECTIVE AGENT; DRUG CARRIER; EYE DROPS;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED RELEASE FORMULATION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG FORMULATION; DRUG SOLUTION; ESCHERICHIA COLI; GEL; GELATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; NONHUMAN; PH; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; VISCOSITY; BIOAVAILABILITY; CHEMISTRY; DRUG ADMINISTRATION ROUTE; EYE; METABOLISM;

ALGINATES; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CIPROFLOXACIN; DRUG ADMINISTRATION ROUTES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ESCHERICHIA COLI; EYE; GELS; METHYLCELLULOSE; OPHTHALMIC SOLUTIONS; POLYMERS;

EID: 70349330509     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540802689008     Document Type: Article

References (28)

1. Schoenwald R. Ocular drug delivery: pharmacokinetics considerations. Clin Pharmacokinet 1990;184:255-269.
2. Middleton D, Leung S, Robinson J. In: Lenaerts V, Gurny R, editors. Bioadhesive drug delivery systems. Boca Raton, FL: CRC Press;1990. p 179-202.
3. Patton T, Robinson J.Ocular evaluation of polyvinyl alcohol vehicle in rabbits. J Pharm Sci 1975;64:1312-1316.
4. Zaki I, Fitzgerald P, Hardy J, Wolson C.A comparison of the effect of viscosity on the precorneal residence of solutions in rabbit and man. J Pharm Pharmacol 1986;3:463-466.
5. Greaves J, Wilson C.Treatment of diseases of the eyes with mucoadhesive delivery systems. Adv Drug Deliv Rev 1993;11: 349-383.
6. Miller S, Donovan M.Effect of polaxomer 407 gel in the miotic activity of polocarpine nitrate in rabbits. Int J Pharm 1982;12:147-152.
7. Lindell K, Engstrom S.In vitro release of timolol maleate from an in situ gelling polymer system. Int J Pharm 1993;95:219-228.
8. Gurny R.Preliminary study of prolonged acting drug delivery system for the treatment of glaucoma. Pharm Acta Helv 1981;56:130-132.
9. Srividya B, Cardoza R, Amin P.Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. J Contr Rel 2001;73:205-211.
10. Carfors J, Edsman K, Petersson R, Jornving K.Rheological evaluation of gelrite in situ gels for ophthalmic use. Eur J Pharm Sci 1998;6:113-119. (Pubitemid 28164281)
11. Cohen S, Lobel E, Trevgoda A, Peled Y.A novel in situ-forming ophthalmic drug delivery system from alginates undergoing gelation in the eye. J Contr Rel 1997;44:201-208.
12. Liu Z, Li J, Nie S, Liu H, Ding P, Pan W.Study of an alginate/HPMCbased in situ gelling ophthalmic delivery system for gatifloxacin. Int J Pharm 2006;315:12-17.
13. Goodman L, Gilman A.The pharmacological basis of therapeutics, 9th ed. New York: McGraw-Hill;1996. p 1065.
14. Appelbaum P, Hunter P.The fluoroquinolone antibacterials: past, present, and future perspectives. Int J Antimicrob Agents 2000;16:5-15.
15. Vilches A, Jilmenez-Kairuz A, Alovero F, Olivera M, Allemandi D, Manzo R.Release kinetics and uptake studies model fluoroquinolones from carbomer hydrogels. Int J Pharm 2002;246:17-24.
16. Allemandi D, Alovero F, Manzo R.Formulation of a neutral solution of ciprofloxacin upon complexation with aluminium. II Farmaco 1999;54:758-760.
17. Lin H, Ko S, Hsu L, Tsai Y.The preparation of norfloxacin-loaded liposomes and their in-vitro evaluation in pig's eye. J Pharm Pharmacol 1996;48:801-805.
18. Thomson Micromedex.MICROMEDEX (R), Healthcare series, 116.: Thomson Micromedex, Washington, D. C., USA;2003.
19. Vo'oleghem M.. In: Edman P, editor. Biopharmaceutics of ocular drug delivery. Boca Raton, FL: CRC Press;1993. p 27-41.
20. Agrwal V, Mishra B.Design, development and biopharmaceutical properties of buccoadhesive compacts of pentazocine. Drug Dev Ind Pharm 1990;25:701-709.
21. Kawazu K, Takashina H, Kawashima Y, Usui M, Mitsui Y.Effect of pH on the ocular penetration of levofloxacin. Atarashil Ganka 1996;13:259-262.
22. Smart J, Kellaway I, Worthington H.An in vitro investigation of mucosa-adhesive materials for use in controlled drug delivery. J Pharm Pharmacol 1984;36:259-299.
23. Ferrari F, Bertoni M, Caramella C, Lamanna A.Description and validation of an apparatus for gel strength measurements. Int J Pharm 1994;109:115-124.
24. Jones D, Woolfson A, Brown A, Coulter W, McClelland C, Irwin C.Design, characterisation and preliminary clinical evaluation of a novel mucoadhesive topical formulation containing tetracycline for the treatment of periodontal diseases. J Contr Rel 2000;67:357-368.
25. Choi H, Hung J, Ryu J, Yoon S, Oh Y, Kim C.Development of insitu gelling and mucoadhesive acetaminophen liquid suppository. Int J Pharm 1998;165:33-44. (Pubitemid 28218342)
26. Wang Y, Hong C, Chiu W, Fan J.In vitro and in vivo evaluations of topically applied capsaicin and nonivamide from hydrogels. Int J Pharm 2001;224:89-104.
27. Korsmeyer R, Gurny R, Doelker E, Buri P, Peppas N.Mechanism of solute release from porous hydrophilic polymers. Int J Pharm 1983;15:25-35.
28. Choi H, Oh Y, Kim C.In situ gelling and mucoadhesive liquid suppository containing acetaminophen: enhanced bioavailability. Int J Pharm 1998;165:23-32.